Feedback / Questions
berubicin (RTA 744) - Reata
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-acquired-worldwide-rights-for-brain-cancer-drug-from-houston-pharmaceuticals-300960582.html
Nov 19, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next